Robert Bindert Huizinga serves as Executive at Aurinia Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Robert Bindert Huizinga has executed 13 insider transactions totaling $5.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 2, 2022 involved receiving (via award) 8,500 shares valued at $0.
Robert Bindert Huizinga currently holds 74,228 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Bindert Huizinga has been a net seller of AUPH stock. They have purchased $0 and sold $5.5M worth of shares.
Robert Bindert Huizinga's most recent insider trade was on Mar 2, 2022, when they sold 8,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $12.01 |
| Discretionary |
| Oct 25, 2021 | AUPH | $3.9M | Sale | 130,000 | $29.75 | Discretionary |
| Oct 25, 2021 | AUPH | $304.0K | Option Exercise | 95,000 | $3.20 | Discretionary |
| Sep 21, 2021 | AUPH | $42.1K | Option Exercise | 16,000 | $2.63 | Discretionary |
| Sep 21, 2021 | AUPH | $126.9K | Sale | 5,364 | $23.66 | Discretionary |
| Sep 21, 2021 | AUPH | $35.6K | Option Exercise | 11,136 | $3.20 | Discretionary |
| Sep 21, 2021 | AUPH | $652.6K | Sale | 27,136 | $24.05 | Discretionary |
| Sep 14, 2021 | AUPH | $489.4K | Sale | 22,500 | $21.75 | Discretionary |
| Sep 10, 2021 | AUPH | $99.2K | Sale | 5,000 | $19.83 | Discretionary |
| Sep 10, 2021 | AUPH | $98.8K | Sale | 5,000 | $19.76 | Discretionary |
| Sep 7, 2021 | AUPH | $91.5K | Sale | 5,000 | $18.30 | Discretionary |
| May 11, 2021 | AUPH | $120.8K | Option Exercise | 40,000 | $3.02 | Discretionary |